Clinical status of patients with coronary artery disease post COVID-19
Keywords:
artery disease, clinical status, COVID-19, lung tissue damage, SARS-CoV-2Abstract
The main goal of our study was to identify the activity of cardiac dysfunction based on the analysis of the main cardiological methods of research, such as ECG, echocardiography, 24-hour ECG monitoring in conjunction with laboratory parameters in patients with coronary artery disease (CAD) who underwent mild and moderate COVID-19, without signs of residual effects of lung tissue damage (fibrotization). 52 patients with coronary artery disease were examined, which were divided into 2 groups depending on the past infection in history: 1 group without COVID-19 in history (n=26) (based on history and results of SARS-CoV-2 antibody titer), 2 a group with a history of COVID-19 (n=26), confirmed by relevant documents (tests), but without oxygen therapy and steroids, in order to avoid the influence of a serious illness and drug exposure. Conclusions: dynamic monitoring of hemostasis parameters after the hospital stage in patients with CAD should be carried out in order to prevent adverse cardiovascular outcomes, even with a history of moderate and mild coronavirus infection. One of the aspects of therapeutic rehabilitation in the post-COVID period in patients with IHD is the use of vitamin D preparations.
Downloads
References
Akhmerov, A., & Marbán, E. (2020). COVID-19 and the heart. Circulation research, 126(10), 1443-1455.
Allen, R. H., Stinson, E. B., Oyer, P. E., & Shumway, N. E. (1978). Predictive variables in reoperation for coronary artery disease. The Journal of Thoracic and Cardiovascular Surgery, 75(2), 186-192. https://doi.org/10.1016/S0022-5223(19)41285-3
Angeli, F., Marazzato, J., Verdecchia, P., Balestrino, A., Bruschi, C., Ceriana, P., ... & Bachetti, T. (2021). Joint effect of heart failure and coronary artery disease on the risk of death during hospitalization for COVID-19. European Journal of Internal Medicine, 89, 81-86. https://doi.org/10.1016/j.ejim.2021.04.007
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., ... & Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The lancet, 395(10223), 507-513.
Chikina, S. Y., Brovko, M. Y., Royuk, V. V., & Avdeev, S. N. (2020). An unusual course of COVID-19 infection with late increase in C-reactive protein (clinical case reports). Pulmonologiya, 30(5), 709-714.
Gupta, Y. S., Finkelstein, M., Manna, S., Toussie, D., Bernheim, A., Little, B. P., ... & Hota, P. (2021). Coronary artery calcification in COVID-19 patients: an imaging biomarker for adverse clinical outcomes. Clinical imaging, 77, 1-8. https://doi.org/10.1016/j.clinimag.2021.02.016
Heusch, G., Libby, P., Gersh, B., Yellon, D., Böhm, M., Lopaschuk, G., & Opie, L. (2014). Cardiovascular remodelling in coronary artery disease and heart failure. The Lancet, 383(9932), 1933-1943. https://doi.org/10.1016/S0140-6736(14)60107-0
Hussin, D. A., Samah, M. A. A., Suhaimi, A. A., & Kamarudin, M. K. A. (2021). A study on knowledge, attitude and practice of COVID-19 pandemic among the residents. International Journal of Health Sciences, 5(2), 177-188. https://doi.org/10.29332/ijhs.v5n2.1378
Jang, Y., Lincoff, A. M., Plow, E. F., & Topol, E. J. (1994). Cell adhesion molecules in coronary artery disease. Journal of the American College of Cardiology, 24(7), 1591-1601. https://doi.org/10.1016/0735-1097(94)90162-7
Lubrano, V., & Balzan, S. (2015). Consolidated and emerging inflammatory markers in coronary artery disease. World journal of experimental medicine, 5(1), 21.
Mitrani, R. D., Dabas, N., & Goldberger, J. J. (2020). COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors. Heart rhythm, 17(11), 1984-1990. https://doi.org/10.1016/j.hrthm.2020.06.026
Pasceri, V., Willerson, J. T., & Yeh, E. T. (2000). Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation, 102(18), 2165-2168.
Raxmatillaevna, K. M., & Karimovich, K. U. (2021). The Relationship between the Degree of Lung Damage and Indicators of the Hemostasis System in Patients with Cardiovascular Diseases against the Background of COVID-19. Annals of the Romanian Society for Cell Biology, 6111-6117.
Sattar, Y., Ullah, W., Rauf, H., Yadav, S., Chowdhury, M., Connerney, M., ... & Alraies, M. C. (2020). COVID-19 cardiovascular epidemiology, cellular pathogenesis, clinical manifestations and management. IJC Heart & Vasculature, 29, 100589. https://doi.org/10.1016/j.ijcha.2020.100589
Scoccia, A., Gallone, G., Cereda, A., Palmisano, A., Vignale, D., Leone, R., ... & Toselli, M. (2021). Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19. Atherosclerosis, 328, 136-143. https://doi.org/10.1016/j.atherosclerosis.2021.03.041
Shchikota, A. M., Pogonchenkova, I. V., Turova, E. A., & Rassulova, M. A. (2020). Cardiac rehabilitation during the COVID-19 pandemic: a review of the literature. Doctor. Ru , 19 (11), 6-11.
Siti, H. N., Kamisah, Y., & Kamsiah, J. J. V. P. (2015). The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review). Vascular pharmacology, 71, 40-56. https://doi.org/10.1016/j.vph.2015.03.005
Thomas, E. S., Most, A. S., & Williams, D. O. (1988). Coronary angioplasty for patients with multivessel coronary artery disease: follow-up clinical status. American Heart Journal, 115(1), 8-13. https://doi.org/10.1016/0002-8703(88)90511-X
Todurov, B., Bitsadze, A., & Shorikova, D. (2021). Early postoperative complications in patients with acute myocardial infarction during emergency coronary bypassing. International Journal of Health Sciences, 5(3), 550-564. https://doi.org/10.53730/ijhs.v5n3.2381
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., ... & Peng, Z. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama, 323(11), 1061-1069.
Wu, Z., & McGoogan, J. M. (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. jama, 323(13), 1239-1242.
Yavelov, I. S., & Drapkina, O. M. (2020). COVID-19: Hemostatic parameters and specifics of antithrombotic treatment. Cardiovascular therapy and prevention, 19(3), 2571.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health & medical sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health & Medical Sciences (IJHMS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHMS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHMS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
